Technetium Tc-99m Apcitide Patent Expiration

Technetium Tc-99M Apcitide was first introduced by Cis Bio International Sa in its drug Acutect on Sep 14, 1998.


Technetium Tc-99m Apcitide Patents

Given below is the list of patents protecting Technetium Tc-99m Apcitide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Acutect US5645815 Radiolabled compounds for thrombus imaging Jul 08, 2014

(Expired)

Cis Bio Intl Sa
Acutect US5508020 Technetium-99M labeled peptides for imaging Apr 16, 2013

(Expired)

Cis Bio Intl Sa
Acutect US5443815 Technetium-99m labeled peptides for imaging Aug 22, 2012

(Expired)

Cis Bio Intl Sa



Technetium Tc-99m Apcitide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List